22nd May 2025
A new strategy to help powerful cancer-targeting immune cells, known as CAR-T cells, infiltrate pancreatic tumours has been developed by researchers at Barts Cancer Institute, Queen Mary University of London. The unique three-pronged approach could pave the way for making CAR-T cell therapy—a treatment that has transformed care for certain blood cancers—effective against pancreatic cancer, a disease that remains very difficult to treat.
Read more19th December 2023
We spoke to Professor Richard Grose about his lab’s latest study, which uses mini-tumours to understand how pancreatic cancer coerces normal cells to help it spread to other tissues. The new paper has been featured on the cover of the latest issue of the Journal of Pathology.
Read more14th December 2023
Congratulations to Dr Mirjana Efremova who has been awarded a £1m grant to use cutting-edge computational tools to study how bowel cancer adapts.
Read more16th November 2023
‘Star-shaped’ cells in the pancreas emit molecules that alter the tumour’s aggressiveness
Read more18th October 2023
Researchers have pinpointed the cells that drive the spread of pancreatic cancer and revealed a weakness in these cells that could be targeted using existing cancer drugs.
Read more23rd August 2023
Researchers show how cancer cells rearrange their inner workings to squeeze between obstacles
Read more